Structural assessment of novel spiro-naphthalene-1.2'- [1,3,4] oxadiazol-4-ones prepared under batch and flow chemistry with a concise antifungal and anti(myco)bacterial activity
| dc.contributor.author | Saleh, Lange Yakubu | |
| dc.contributor.author | Altintas, Bahadir | |
| dc.contributor.author | Filiciotto, Layla | |
| dc.contributor.author | Zorlu, Yunus | |
| dc.contributor.author | Luque, Rafael | |
| dc.contributor.author | Ulger, Mahmut | |
| dc.contributor.author | Dondas, H. Ali | |
| dc.date.accessioned | 2025-10-29T11:21:21Z | |
| dc.date.issued | 2023 | |
| dc.department | Fakülteler, Temel Bilimler Fakültesi, Kimya Bölümü | |
| dc.description.abstract | The reaction of hydrazonyl chlorides with 2,3-dichloro-1,4-naphthoquinone yielded pharmaceutically important spiro-naphthalene-1,2'-[1,3,4]oxadiazol-4-ones under batch and flow synthesis methods. The regioselective cycloaddition protocol operates under mild conditions, tolerates a wide range of structural moieties and delivers versatile spiro-oxadiazole motif with high efficiency. The obtained products were elucidated by IR, 1H NMR, 13C NMR, HRMS and compound 6h was characterized by single crystal X-ray diffraction technique. The synthesized molecules have been subjected to theoretical analysis by quantum chemical calculations at DFT/B3LYP/def2-TVZP level, which provided supporting data for the experi-mental findings. In addition, a concise biological evaluation of some selected novel spirocyclic molecules is reported.(c) 2022 Elsevier Ltd. All rights reserved. | |
| dc.description.sponsorship | Tubitak [2219, 2018.03.03.1311] | |
| dc.description.sponsorship | Cukurova University | |
| dc.description.sponsorship | The authors thank Tubitak 2219 program and BAIBU BAP Project No: 2018.03.03.1311 and we also gratefully acknowledge support from Cukurova University. | |
| dc.identifier.doi | 10.1016/j.tet.2022.133231 | |
| dc.identifier.issn | 0040-4020 | |
| dc.identifier.issn | 1464-5416 | |
| dc.identifier.orcid | 0000-0001-5216-1226 | |
| dc.identifier.scopus | 2-s2.0-85146077205 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.uri | https://doi.org/10.1016/j.tet.2022.133231 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14854/9001 | |
| dc.identifier.volume | 131 | |
| dc.identifier.wos | WOS:000964746200001 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Pergamon-Elsevier Science Ltd | |
| dc.relation.ispartof | Tetrahedron | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20251020 | |
| dc.subject | Flow chemistry | |
| dc.subject | Cycloaddition reaction | |
| dc.subject | 1 | |
| dc.subject | 3 | |
| dc.subject | 4-Oxadiazole | |
| dc.subject | DFT | |
| dc.subject | X-ray diffraction | |
| dc.subject | anti(myco)bacterial | |
| dc.title | Structural assessment of novel spiro-naphthalene-1.2'- [1,3,4] oxadiazol-4-ones prepared under batch and flow chemistry with a concise antifungal and anti(myco)bacterial activity | |
| dc.type | Article |








